Toshimi Imai

475 citations
30 papers · 340 indexed · h-index 9

Toshimi Imai

28 papers receiving 336 citations

Peers

Toshimi Imai
Comparison fields: 5 of 72
  • Nephrology 76
  • Endocrinology, Diabetes and Metabolism 86
  • Cancer Research 55
  • Hepatology 26
  • Surgery 113
Replace Xuehong Lu with:
Xuehong Lu China
Lama Noureddine United States
Johannes Nordlohne Germany
Yanyan He China
Tetsuya Mitarai Japan
Xuezhi Zhao China
Stjepko Pleština Croatia
Sasha Z. Prisco United States
Omri Nativ Israel
Toshimi Imai relative to Xuehong Lu China Xuehong Lu's profile →
Citations per field
00.5×2.9×
Xuehong Lu · 1×
Citations per year

Countries citing papers authored by Toshimi Imai

Since Specialization
Citations

This map shows the geographic impact of Toshimi Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshimi Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshimi Imai more than expected).

Fields of papers citing papers by Toshimi Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshimi Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshimi Imai. The network helps show where Toshimi Imai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Toshimi Imai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toshimi Imai Line = papers co-authored together Toshimi Imai links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20231
3 202212
4 20211
5 20194
6 201817
7 201852
8 20172
9 20173
10 20162
11 20163
12 20150
13 201586
14 201526
15 20155
16 20146
17 20131
18 201213
19 20117
20
DNA microarray analysis of the epithelial-mesenchymal transition of mesothelial cells in a rat model of peritoneal dialysis.
20114

About Toshimi Imai

Toshimi Imai is a scholar working on Nephrology, Internal Medicine and Hepatology, having authored 30 papers that have together received 340 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (7 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers), Renal Diseases and Glomerulopathies (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Muscle and Compartmental Disorders (3 papers), Renal and Vascular Pathologies (3 papers), Diabetes Treatment and Management (3 papers) and Vasculitis and related conditions (3 papers). The work is most often cited by research in Nephrology (76 citations), Endocrinology, Diabetes and Metabolism (86 citations) and Cancer Research (55 citations). Toshimi Imai has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Shigeaki Muto, Minami Watanabe, Daisuke Nagata, Hiromichi Yoshizawa, Yoshiyuki Morishita, Kenichi Ishibashi, Tetsu Akimoto, Takahiro Masuda, Daisuke Nagata and Ken Ohara. Their work appears in journals such as SHILAP Revista de lepidopterología, American Journal of Physiology-Renal Physiology and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026